{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:59:12Z","timestamp":1788346752988,"version":"build-2803163510"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.nbd.2024.106523","type":"journal-article","created":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T02:05:48Z","timestamp":1714788348000},"page":"106523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Shaping down syndrome brain cognitive and molecular changes due to aging using adult animals from the Ts66Yah murine model"],"prefix":"10.1016","volume":"196","author":[{"given":"Chiara","family":"Lanzillotta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika Rataj","family":"Baniowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Prestia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Sette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Nalesso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Perluigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Duchon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Tramutola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Herault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Di Domenico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.nbd.2024.106523_bb0005","article-title":"PGC-1alpha is a master regulator of mitochondrial lifecycle and ROS stress response","volume":"12","author":"Abu Shelbayeh","year":"2023","journal-title":"Antioxidants (Basel)"},{"issue":"1","key":"10.1016\/j.nbd.2024.106523_bb0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","article-title":"Down syndrome","volume":"6","author":"Antonarakis","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"3","key":"10.1016\/j.nbd.2024.106523_bb0015","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0887-8994(96)00167-1","article-title":"Excessive glutamate receptor 1 immunoreactivity in adult down syndrome brains","volume":"15","author":"Arai","year":"1996","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.nbd.2024.106523_bb0020","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pharmthera.2018.09.010","article-title":"DYRK1A and cognition: a lifelong relationship","volume":"194","author":"Arbones","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.nbd.2024.106523_bb0025","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.freeradbiomed.2021.09.006","article-title":"The interplay among oxidative stress, brain insulin resistance and AMPK dysfunction contribute to neurodegeneration in type 2 diabetes and Alzheimer disease","volume":"176","author":"Barone","year":"2021","journal-title":"Free Radic. Biol. Med."},{"issue":"11","key":"10.1016\/j.nbd.2024.106523_bb0030","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/jamaneurol.2018.2210","article-title":"Prevalence of aging, Dementia, and Multimorbidity in Older Adults With Down Syndrome","volume":"75","author":"Bayen","year":"2018","journal-title":"JAMA Neurol"},{"issue":"8","key":"10.1016\/j.nbd.2024.106523_bb0035","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41419-019-1752-5","article-title":"mTOR hyperactivation in down syndrome underlies deficits in autophagy induction, autophagosome formation, and mitophagy","volume":"10","author":"Bordi","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.nbd.2024.106523_bb0040","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/bs.pbr.2019.10.002","article-title":"Focusing on cellular biomarkers: the endo-lysosomal pathway in down syndrome","volume":"251","author":"Botte","year":"2020","journal-title":"Prog. Brain Res."},{"issue":"1","key":"10.1016\/j.nbd.2024.106523_bb0045","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s40478-020-00956-z","article-title":"Ultrastructural and dynamic studies of the endosomal compartment in down syndrome","volume":"8","author":"Botte","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"issue":"11","key":"10.1016\/j.nbd.2024.106523_bb0050","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1128\/MCB.02393-05","article-title":"Phosphorylation of amyloid precursor protein (APP) at Thr668 regulates the nuclear translocation of the APP intracellular domain and induces neurodegeneration","volume":"26","author":"Chang","year":"2006","journal-title":"Mol. Cell. Biol."},{"issue":"6","key":"10.1016\/j.nbd.2024.106523_bb0055","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1111\/j.1471-4159.2009.06277.x","article-title":"Age-dependent dysregulation of brain amyloid precursor protein in the Ts65Dn down syndrome mouse model","volume":"110","author":"Choi","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2024.106523_bb0060","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.pnpbp.2017.11.016","article-title":"PSD95: a synaptic protein implicated in schizophrenia or autism?","volume":"82","author":"Coley","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"6489","key":"10.1016\/j.nbd.2024.106523_bb0065","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat5314","article-title":"The integrated stress response: from mechanism to disease","volume":"368","author":"Costa-Mattioli","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.nbd.2024.106523_bb0070","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3389\/fnins.2019.00292","article-title":"The role of PGC-1alpha\/UCP2 signaling in the beneficial effects of physical exercise on the brain","volume":"13","author":"de Oliveira Bristot","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2024.106523_bb0075","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/bs.apcsb.2022.05.008","article-title":"The disturbance of protein synthesis\/degradation homeostasis is a common trait of age-related neurodegenerative disorders","volume":"132","author":"Di Domenico","year":"2022","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"10.1016\/j.nbd.2024.106523_bb0080","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.freeradbiomed.2014.03.027","article-title":"Redox proteomics analysis of HNE-modified proteins in down syndrome brain: clues for understanding the development of Alzheimer disease","volume":"71","author":"Di Domenico","year":"2014","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.nbd.2024.106523_bb0085","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3233\/JAD-141254","article-title":"Bach1 overexpression in down syndrome correlates with the alteration of the HO-1\/BVR-a system: insights for transition to Alzheimer\u2019s disease","volume":"44","author":"Di Domenico","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"11\u201312","key":"10.1016\/j.nbd.2024.106523_bb0090","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1080\/14789450.2019.1691919","article-title":"Shining a light on defective autophagy by proteomics approaches: implications for neurodegenerative illnesses","volume":"16","author":"Di Domenico","year":"2019","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.nbd.2024.106523_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101162","article-title":"Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: focus on HNE-modified proteins in a mouse model of down syndrome","volume":"23","author":"Di Domenico","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.nbd.2024.106523_bb0100","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3389\/fnins.2020.00670","article-title":"Down syndrome is a metabolic disease: altered insulin signaling mediates peripheral and brain dysfunctions","volume":"14","author":"Dierssen","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2024.106523_bb0105","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1186\/1756-0500-5-513","article-title":"A simple protocol for the subcellular fractionation of skeletal muscle cells and tissue","volume":"5","author":"Dimauro","year":"2012","journal-title":"BMC. Res. Notes"},{"issue":"2","key":"10.1016\/j.nbd.2024.106523_bb0110","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/JAD-160836","article-title":"Down syndrome, partial trisomy 21, and absence of Alzheimer's disease: the role of APP","volume":"56","author":"Doran","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2024.106523_bb0115","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fnbeh.2016.00104","article-title":"DYRK1A, a dosage-sensitive gene involved in neurodevelopmental disorders, Is a Target for Drug Development in Down Syndrome","volume":"10","author":"Duchon","year":"2016","journal-title":"Front. Behav. Neurosci."},{"issue":"11\u221212","key":"10.1016\/j.nbd.2024.106523_bb0120","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00335-011-9356-0","article-title":"Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling down syndrome","volume":"22","author":"Duchon","year":"2011","journal-title":"Mamm. Genome"},{"issue":"12","key":"10.1016\/j.nbd.2024.106523_bb0125","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.049721","article-title":"Ts66Yah, a mouse model of down syndrome with improved construct and face validity","volume":"15","author":"Duchon","year":"2022","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.nbd.2024.106523_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101930","article-title":"Untangle the mystery behind DS-associated AD - is APP the main protagonist?","volume":"87","author":"Elangovan","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.nbd.2024.106523_bb0135","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00726-015-2062-6","article-title":"Reduced cortical neurotransmitter receptor complex levels in fetal down syndrome brain","volume":"48","author":"Falsafi","year":"2016","journal-title":"Amino Acids"},{"key":"10.1016\/j.nbd.2024.106523_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.909669","article-title":"Rodent modeling of Alzheimer's disease in down syndrome: in vivo and ex vivo approaches","volume":"16","author":"Farrell","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2024.106523_bb0145","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/978-3-319-16522-6_12","article-title":"Assessing cognitive improvement in people with down syndrome: important considerations for drug-efficacy trials","volume":"228","author":"Fernandez","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.nbd.2024.106523_bb0150","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cotox.2018.05.002","article-title":"mTOR\/AMPK signaling in the brain: cell metabolism, proteostasis and survival","volume":"8","author":"Garza-Lombo","year":"2018","journal-title":"Curr. Opin. Toxicol."},{"key":"10.1016\/j.nbd.2024.106523_bb0155","article-title":"The impact of Mmu17 non-Hsa21 orthologous genes in the Ts65Dn mouse model of down syndrome: the gold standard refuted","volume":"1; 94 (1): 84-97","author":"Guedj","year":"2023","journal-title":"Biol. Psychiatry."},{"issue":"11\u201312","key":"10.1016\/j.nbd.2024.106523_bb0160","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s00335-016-9661-8","article-title":"Mouse models of down syndrome: gene content and consequences","volume":"27","author":"Gupta","year":"2016","journal-title":"Mamm. Genome"},{"issue":"11","key":"10.1016\/j.nbd.2024.106523_bb0165","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1002\/ajmg.a.38465","article-title":"Pharmacological interventions to improve cognition and adaptive functioning in down syndrome: strides to date","volume":"173","author":"Hart","year":"2017","journal-title":"Am. J. Med. Genet. A"},{"issue":"10","key":"10.1016\/j.nbd.2024.106523_bb0170","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1242\/dmm.029728","article-title":"Rodent models in down syndrome research: impact and future opportunities","volume":"10","author":"Herault","year":"2017","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.nbd.2024.106523_bb0175","doi-asserted-by":"crossref","first-page":"5497046","DOI":"10.1155\/2020\/5497046","article-title":"Proteostasis failure in neurodegenerative diseases: focus on oxidative stress","volume":"2020","author":"Hohn","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"2","key":"10.1016\/j.nbd.2024.106523_bb0180","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0166-4328(02)00275-9","article-title":"Behavioral comparison of 4 and 6 month-old Ts65Dn mice: age-related impairments in working and reference memory","volume":"138","author":"Hunter","year":"2003","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.nbd.2024.106523_bb0185","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s10020-018-0004-y","article-title":"Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets","volume":"24","author":"Izzo","year":"2018","journal-title":"Mol. Med."},{"key":"10.1016\/j.nbd.2024.106523_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.941855","article-title":"Neurodevelopment in down syndrome: concordance in humans and models","volume":"16","author":"Klein","year":"2022","journal-title":"Front. Cell. Neurosci."},{"issue":"6","key":"10.1016\/j.nbd.2024.106523_bb0195","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.devcel.2008.10.014","article-title":"The protein kinase DYRK1A regulates caspase-9-mediated apoptosis during retina development","volume":"15","author":"Laguna","year":"2008","journal-title":"Dev. Cell"},{"issue":"2","key":"10.1016\/j.nbd.2024.106523_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/biom11020266","article-title":"Stress responses in down syndrome neurodegeneration: state of the art and therapeutic molecules","volume":"11","author":"Lanzillotta","year":"2021","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.nbd.2024.106523_bb0205","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3233\/JAD-170617","article-title":"Early and selective activation and subsequent alterations to the unfolded protein response in down syndrome mouse models","volume":"62","author":"Lanzillotta","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2024.106523_bb0210","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.freeradbiomed.2021.01.042","article-title":"Insulin resistance, oxidative stress and mitochondrial defects in Ts65dn mice brain: a harmful synergistic path in down syndrome","volume":"165","author":"Lanzillotta","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.nbd.2024.106523_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2020.101892","article-title":"Chronic PERK induction promotes Alzheimer-like neuropathology in down syndrome: insights for therapeutic intervention","volume":"196","author":"Lanzillotta","year":"2021","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2024.106523_bb0220","first-page":"15","article-title":"Effects of p21 on adult hippocampal neuronal development after irradiation","volume":"4","author":"Li","year":"2018","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.nbd.2024.106523_bb0225","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1096\/fj.07-104539","article-title":"Overexpression of Dyrk1A contributes to neurofibrillary degeneration in down syndrome","volume":"22","author":"Liu","year":"2008","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.nbd.2024.106523_bb0230","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41582-018-0132-6","article-title":"Dementia in down syndrome: unique insights for Alzheimer disease research","volume":"15","author":"Lott","year":"2019","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2024.106523_bb0235","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12859-022-05111-0","article-title":"Gdaphen, R pipeline to identify the most important qualitative and quantitative predictor variables from phenotypic data","volume":"24","author":"Muniz Moreno","year":"2023","journal-title":"BMC Bioinformat."},{"issue":"38","key":"10.1016\/j.nbd.2024.106523_bb0240","doi-asserted-by":"crossref","first-page":"10268","DOI":"10.1073\/pnas.1704143114","article-title":"Prenatal neurogenesis induction therapy normalizes brain structure and function in down syndrome mice","volume":"114","author":"Nakano-Kobayashi","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.nbd.2024.106523_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010943","article-title":"Lowering beta-amyloid levels rescues learning and memory in a down syndrome mouse model","volume":"5","author":"Netzer","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.nbd.2024.106523_bb0250","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1038\/s41598-018-20984-z","article-title":"DYRK1A inhibition and cognitive rescue in a down syndrome mouse model are induced by new fluoro-DANDY derivatives","volume":"8","author":"Neumann","year":"2018","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.nbd.2024.106523_bb0255","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.bbadis.2014.04.007","article-title":"Neuropathological role of PI3K\/Akt\/mTOR axis in down syndrome brain","volume":"1842","author":"Perluigi","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2024.106523_bb0260","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.nbd.2015.03.014","article-title":"mTOR signaling in aging and neurodegeneration: at the crossroad between metabolism dysfunction and impairment of autophagy","volume":"84","author":"Perluigi","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"8","key":"10.1016\/j.nbd.2024.106523_bb0265","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/alz.12499","article-title":"Aberrant crosstalk between insulin signaling and mTOR in young down syndrome individuals revealed by neuronal-derived extracellular vesicles","volume":"18","author":"Perluigi","year":"2022","journal-title":"Alzheimers Dement."},{"issue":"11\u201312","key":"10.1016\/j.nbd.2024.106523_bb0270","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00335-011-9357-z","article-title":"Molecular characterization of the translocation breakpoints in the down syndrome mouse model Ts65Dn","volume":"22","author":"Reinholdt","year":"2011","journal-title":"Mamm. Genome"},{"issue":"8","key":"10.1016\/j.nbd.2024.106523_bb0275","article-title":"Antioxidants in down syndrome: from preclinical studies to clinical trials","volume":"9","author":"Rueda Revilla","year":"2020","journal-title":"Antioxidants (Basel)"},{"issue":"48","key":"10.1016\/j.nbd.2024.106523_bb0280","doi-asserted-by":"crossref","first-page":"34850","DOI":"10.1074\/jbc.M707358200","article-title":"DYRK1A-mediated hyperphosphorylation of tau. A functional link between Down syndrome and Alzheimer disease","volume":"282","author":"Ryoo","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"Pt A","key":"10.1016\/j.nbd.2024.106523_bb0285","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.expneurol.2016.06.006","article-title":"Experience-dependent reduction of soluble beta-amyloid oligomers and rescue of cognitive abilities in middle-age Ts65Dn mice, a model of down syndrome","volume":"283","author":"Sansevero","year":"2016","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.nbd.2024.106523_bb0290","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.expneurol.2004.11.017","article-title":"Abnormal APP, cholinergic and cognitive function in Ts65Dn Down\u2019s model mice","volume":"193","author":"Seo","year":"2005","journal-title":"Exp. Neurol."},{"issue":"7","key":"10.1016\/j.nbd.2024.106523_bb0295","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1601-183X.2008.00428.x","article-title":"Molecular responses of the Ts65Dn and Ts1Cje mouse models of down syndrome to MK-801","volume":"7","author":"Siddiqui","year":"2008","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.nbd.2024.106523_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2022.12.003","article-title":"Mitochondrial dysfunction in down syndrome: from pathology to therapy","volume":"511","author":"Tan","year":"2023","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.nbd.2024.106523_bb0305","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00335-021-09930-z","article-title":"Mouse models of aneuploidy to understand chromosome disorders","volume":"33","author":"Tosh","year":"2022","journal-title":"Mamm. Genome"},{"issue":"1","key":"10.1016\/j.nbd.2024.106523_bb0310","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3233\/JAD-151105","article-title":"Activation of p53 in down syndrome and in the Ts65Dn mouse brain is associated with a pro-apoptotic phenotype","volume":"52","author":"Tramutola","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2024.106523_bb0315","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40035-018-0133-9","article-title":"Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of down syndrome","volume":"7","author":"Tramutola","year":"2018","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.nbd.2024.106523_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104772","article-title":"Brain insulin resistance triggers early onset Alzheimer disease in down syndrome","volume":"137","author":"Tramutola","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.nbd.2024.106523_bb0325","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.bbadis.2016.03.003","article-title":"The polyphenols resveratrol and epigallocatechin-3-gallate restore the severe impairment of mitochondria in hippocampal progenitor cells from a down syndrome mouse model","volume":"1862","author":"Valenti","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.nbd.2024.106523_bb0330","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nm.3117","article-title":"Loss of sorting nexin 27 contributes to excitatory synaptic dysfunction by modulating glutamate receptor recycling in Down\u2019s syndrome","volume":"19","author":"Wang","year":"2013","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.nbd.2024.106523_bb0335","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.4161\/auto.24135","article-title":"After the banquet: mitochondrial biogenesis, mitophagy, and cell survival","volume":"9","author":"Zhu","year":"2013","journal-title":"Autophagy"},{"issue":"6467","key":"10.1016\/j.nbd.2024.106523_bb0340","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.aaw5185","article-title":"Activation of the ISR mediates the behavioral and neurophysiological abnormalities in down syndrome","volume":"366","author":"Zhu","year":"2019","journal-title":"Science"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996124001220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996124001220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T16:25:31Z","timestamp":1716999931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996124001220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":68,"alternative-id":["S0969996124001220"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2024.106523","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shaping down syndrome brain cognitive and molecular changes due to aging using adult animals from the Ts66Yah murine model","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2024.106523","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106523"}}